[Drug-resistant headache: is it the end?].
Chronic primary headache often cause significant interference with function and quality of life despite acute and preventive medicines. New treatments are emerging for pharmacologically intractable cluster headache and migraine. Occipital nerve stimulation in chronic cluster headache and botulinum toxin in chronic migraine represent the most promising therapies.
Service de neurologie, Département des neurosciences cliniques, CHUV, 101 I Lausanne et 2, chemin des Croix-Rouges, 1007 Lausanne. bernardnater@bluewin.ch
Bernard
B
Nater
Catherine
C
Dozier
D000700:Analgesics / Q000627:therapeutic use*; D003027:Cluster Headache / Q000209:etiology / Q000628:therapy; D004351:Drug Resistance / Q000502:physiology; D006261:Headache / Q000188:drug therapy*; D020773:Headache Disorders / Q000188:drug therapy*; D006801:Humans; D008881:Migraine Disorders / Q000209:etiology / Q000628:therapy; D009462:Neurology / Q000379:methods / Q000639:trends
D000700:Analgesics